Services

testing wound-healing activity

Cell migration is an important physiological process during embryogenesis, tissue regeneration and wound-healing, but is also associated with pathological situation such as tumor development, metastasis or inflammation.

In order to screen for substances that favor or inhibit cell migration the scratch assay is widely used. Evercyte offers services to test cell migration into a physical gap and test wound-healing activities of certain compounds.

Related Services

testing the potency of extracellular vesicles / exosomes

fHDF/TERT166

telomerized human foreskin fibroblasts

MSCs for production of clinical grade extracellular vesicles

Customer Reviews

“I have had the pleasure of working with Evercyte for the last few years. We continually rely on Evercyte because of the high-quality data that they produce, their diligent responsiveness, and their excellent customer service.”

 

Josh Garlich, Senior Research Scientist, Apellis Pharmaceuticals, Inc.

"Cytonus has been working with Evercyte from many years as they are a trusted partner and have always delivered the highest quality cell lines to advance our platform.  We routinely draw on their expertise to meet cellular engineering challenges and they have not disappointed."

Remo Moomiaie-Qajar, Cytonus Therapeutics, Inc.

all about our
EV cell factories

fHDF/TERT166

telomerized human skin fibroblasts are a relevant and standardizable model system to study wound healing activities in vitro

Related Services

characterization of extracellular vesicles / exosomes to exert fibroblast growth promoting / wound healing activity using scratch assay

Customer Reviews

“I have had the pleasure of working with Evercyte for the last few years. We continually rely on Evercyte because of the high-quality data that they produce, their diligent responsiveness, and their excellent customer service.”

 

Josh Garlich, Senior Research Scientist, Apellis Pharmaceuticals, Inc.

"Cytonus has been working with Evercyte from many years as they are a trusted partner and have always delivered the highest quality cell lines to advance our platform.  We routinely draw on their expertise to meet cellular engineering challenges and they have not disappointed."

Remo Moomiaie-Qajar, Cytonus Therapeutics, Inc.